Showing results (531-540 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|November 3, 2024
Sex as a biological variable in HIV-1 and schistosome co-infectionJane K Maganga, Khanh Pham, John M Changalucha, et al.
The Lancet. HIV|July 15, 2024
HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trialDavid A Wohl, Christoph D Spinner, Jason Flamm, et al.
The Lancet. HIV|July 12, 2024
Person-centred care for older adults living with HIV in sub-Saharan AfricaDeborah Goldstein, Jepchirchir Kiplagat, Charlotte Taderera, et al.
The Lancet. HIV|June 26, 2024
Effectiveness of integrating HIV prevention within sexual reproductive health services with or without peer support among adolescents and young adults in rural KwaZulu-Natal, South Africa (Isisekelo Sempilo): 2 × 2 factorial, open-label, randomised controlled trialMaryam Shahmanesh, Natsayi Chimbindi, Jacob Busang, et al.
The Lancet. HIV|July 7, 2024
Steatotic liver disease and HIV: an agenda for 2030Juan M Pericàs, Anish K Arora, Carlotta Riebensahm, et al.
The Lancet. HIV|June 9, 2024
Moving beyond hotspots of HIV prevalence to geospatial hotspots of UNAIDS 95-95-95 targets in sub-Saharan AfricaDiego F Cuadros, Qian Huang, Godfrey Musuka, et al.
The Lancet. HIV|October 28, 2023
Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trialGonasagrie Nair, Connie Celum, Daniel Szydlo, et al.
The Lancet. HIV|March 21, 2024
Collective antiretroviral protection: new dimensions of community HIV prevention practices at the intersection of U=U and PrEPJulien B Brisson, Daniel Grace, Amaya G Perez-Brumer
The Lancet. HIV|September 2, 2023
Rapid access to antiretroviral therapy, receipt of naltrexone, and strengths-based case management versus standard of care for HIV viral load suppression in people with HIV who inject drugs in Russia (LINC-II): an open-label, randomised controlled trialJeffrey H Samet, Elena Blokhina, Debbie M Cheng, et al.
The Lancet. HIV|January 27, 2024
Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studiesAdam Trickey, Kathleen McGinnis, M John Gill, et al.
Pageof 79